how safe are glp-1 medications Medications: Everything You Need to Know Ozempic and Hemophilia: Is It

A 2023 study out of the University of British Columbia linked GLP-1 agonists to a heightened risk of severe gastrointestinal problems. These problems include gastroparesis, pancreatitis, and bowel obstruction

After 9 months on Retatrutide, he achieved a 20% weight loss, dramatically improved lipid levels, normalized blood pressure, and decreased CRP by over 50%, profoundly reducing his cardiovascular risk

Normally, patients fast before surgery to reduce this risk, but GLP-1 medications can cause food to remain in the stomach longer than expected, increasing the chance of aspiration even after fasting

Impact of early SGLT2 inhibitors prescription on acute decompensated heart failure outcomes: insights from a real-world setting

Wong, M

2021 Mar 9;12:2042018821997320